Cervical Dysplasia: Clinical Trials

3 trials for Cervical Dysplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Cervical Dysplasia: new trials by email Literature Review of Cervical Dysplasia trials Research Report on Cervical Dysplasia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
VGX-3100, Matched Placebo, CELLECTRAâ„¢-5PSP - Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion
Phase 3CompletedInovio Pharmaceuticals2032019-02-282024-10-17
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
VGX-3100, Placebo, Electroporation (EP) - Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion
Phase 3CompletedInovio Pharmaceuticals2012017-06-282023-07-27
Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
di indolylmethane (DIM), Red rice bran - Cervical Dysplasia
Phase 3CompletedNew York Presbyterian Hospital622000-09-012017-03-29

Narrower conditions

Uterine Cervical Dysplasia (3)  ·  Squamous Intraepithelial Lesions (2)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Neoplasms (3)  ·  Precancerous Conditions (3)  ·  Urogenital Diseases (3)  ·  Uterine Cervical Diseases (3)  ·  Uterine Diseases (3)  ·  Morphological and Microscopic Findings (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

VGX-3100 (2)  ·  Electroporation (1)

Sponsors

Inovio Pharmaceuticals (2)  ·  New York Presbyterian Hospital (1)

Countries

United States (3)  ·  Argentina (2)  ·  Estonia (2)  ·  Finland (2)  ·  Lithuania (2)  ·  Poland (2)  ·  Puerto Rico (2)  ·  South Africa (2)  ·  Spain (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Peru (1)

Top investigators

Jeffrey Skolnik, MD (2)  ·  Alan Arslan, M.D. (1)  ·  Giuseppe Del Priore, M.D., M.P.H. (1)

Results publications

PMID 19939441

NIH funding

2016 (1), 2018 (1)